Stephen Fortmann to Double-Blind Method
This is a "connection" page, showing publications Stephen Fortmann has written about Double-Blind Method.
Connection Strength
0.250
-
Randomized trial of folic acid for prevention of cardiovascular events in end-stage renal disease. J Am Soc Nephrol. 2004 Feb; 15(2):420-6.
Score: 0.058
-
Quitting chew: results from a randomized trial using nicotine patches. Exp Clin Psychopharmacol. 1999 Nov; 7(4):362-71.
Score: 0.043
-
Response to Transdermal Selegiline Smoking Cessation Therapy and Markers in the 15q24 Chromosomal Region. Nicotine Tob Res. 2015 Sep; 17(9):1126-33.
Score: 0.031
-
Perceived drug assignment and treatment outcome in smokers given nicotine patch therapy. J Subst Abuse Treat. 2010 Sep; 39(2):150-6.
Score: 0.023
-
Minimal contact treatment for smoking cessation. A placebo controlled trial of nicotine polacrilex and self-directed relapse prevention: initial results of the Stanford Stop Smoking Project. JAMA. 1988 Sep 16; 260(11):1575-80.
Score: 0.020
-
Design and statistical issues in the homocysteinemia in kidney and end stage renal disease (HOST) study. Clin Trials. 2004; 1(5):451-60.
Score: 0.015
-
Onset of major depression during treatment for nicotine dependence. Addict Behav. 2003 Apr; 28(3):461-70.
Score: 0.014
-
Do men outperform women in smoking cessation trials? Maybe, but not by much. Exp Clin Psychopharmacol. 2002 Aug; 10(3):295-301.
Score: 0.013
-
Nicotine patch and paroxetine for smoking cessation. J Consult Clin Psychol. 2000 Oct; 68(5):883-9.
Score: 0.012
-
Do heavy smokers benefit from higher dose nicotine patch therapy? Exp Clin Psychopharmacol. 1999 Aug; 7(3):226-33.
Score: 0.011
-
Are higher doses of nicotine replacement more effective for smoking cessation? Nicotine Tob Res. 1999 Jun; 1(2):169-74.
Score: 0.011